Centiva Capital’s Colgate-Palmolive CL Stock Holding History

Centiva Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,300	Closed	-$1.74M	–	2112
2024 Q1	$1.74M	Sell	19,300 -30,000	-61%	-$2.54M	0.04%	392
2023 Q4	$3.93M	Sell	49,300 -12,500	-20%	-$940K	0.09%	204
2023 Q3	$4.39M	Buy	61,800 +12,500	+25%	+$935K	0.1%	184
2023 Q2	$3.8M	Buy	+49,300	New	+$3.82M	0.08%	246
2019 Q1	–	Sell	-12,400	Closed	-$738K	–	320
2018 Q4	$738K	Sell	12,400 -4,000	-24%	-$250K	0.06%	165
2018 Q3	$1.1M	Buy	+16,400	New	+$1.09M	0.09%	100

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Centiva Capital's CL Position: Q2 2026 in Review

Centiva Capital opened a new position in Colgate-Palmolive (CL) in Q2 2026: 15,893 shares worth $1.46M. The stake represents 0.01% of the portfolio and ranks #503 among its holdings. This is a return to the name: Centiva Capital previously reported a position in CL as recently as Q2 2025.

Centiva Capital first reported a position in CL in Q3 2018 and has held it in 16 quarters since. The position peaked at $3.65M in Q2 2023. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Centiva Capital held 15,893 shares of Colgate-Palmolive worth $1.46M as of Q2 2026.
Colgate-Palmolive was a new Centiva Capital position in Q2 2026.
Colgate-Palmolive made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #503 holding.
Centiva Capital first reported a position in Colgate-Palmolive in Q3 2018 and has held it in 16 quarters since.
Centiva Capital's Colgate-Palmolive position peaked at $3.65M in Q2 2023.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.